Related Experiment Video
Updated: Jan 27, 2026

An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
Published on: August 14, 2016
Dephosphorylation of Girdin by PP2A inhibits breast cancer metastasis
Jiang Li1, Atsushi Enomoto2, Liang Weng3
1Center for Molecular Medicine, Xiangya Hospital, Central South University, 87 Xiangya Road, 410008, Changsha, Hunan, China.
Abstract:
Dysfunction of Girdin plays a crucial role in the development of a variety of tumors. Phosphorylated regulation of Girdin has been studied extensively. However, how Girdin is dephosphorylated remains unclear. In this study, we report a mechanism of Girdin dephosphorylation and the importance of this mechanism in the migration of breast cancer cells. We show that the protein phosphatase 2A (PP2A) complex can bind to Girdin via the modulating B subunit. Overexpression or knockdown of PP2A inhibits or increases the phosphorylation of Girdin at serine 1416, respectively. PP2Ac-induced Girdin dephosphorylation is involved in the inhibition of breast cancer cell migration. Furthermore, in human breast cancer samples, PP2Ac expression is negatively correlated with the phosphorylation of Girdin, and low expression of PP2Ac is correlated with tumor stage, grade and lymph node metastasis of breast cancer. These data indicate that PP2A regulates Girdin dephosphorylation and highlight the critical role of this pathway in breast cancer metastasis.
Insights
Protein phosphatase 2A (PP2A) dephosphorylates Girdin, inhibiting breast cancer cell migration. Low PP2A expression correlates with advanced tumor stage and metastasis, highlighting a key pathway in cancer progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Girdin dysfunction is implicated in various tumors.
- Girdin phosphorylation is well-studied, but its dephosphorylation mechanism is unknown.
Purpose of the Study:
- To elucidate the mechanism of Girdin dephosphorylation.
- To investigate the role of Girdin dephosphorylation in breast cancer cell migration.
Main Methods:
- Investigated the interaction between protein phosphatase 2A (PP2A) and Girdin.
- Utilized overexpression and knockdown of PP2A to study Girdin phosphorylation at serine 1416.
- Analyzed human breast cancer samples for PP2A expression and Girdin phosphorylation correlation.
Main Results:
- PP2A binds to Girdin via its B subunit.
- PP2A regulates Girdin dephosphorylation at serine 1416.
- PP2A-mediated Girdin dephosphorylation inhibits breast cancer cell migration.
- PP2A expression inversely correlates with Girdin phosphorylation in human breast cancer.
- Low PP2A expression is linked to advanced tumor stage, grade, and lymph node metastasis.
Conclusions:
- PP2A-mediated Girdin dephosphorylation is a critical pathway regulating breast cancer cell migration.
- PP2A represents a potential therapeutic target for breast cancer metastasis.
Related Concept Videos
Feedback Inhibition
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Enzyme Inhibition
Inhibition of Cdk Activity
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...

